, Depression: A Global Crisis, WHO, 2012.
Prevalence of major depression in France in the general population and in specific populations from, Presse Med. Paris Fr, vol.48, pp.365-375, 1983. ,
The key role of psychiatry in the development of French health-related sustainable development goals, L'Encephale, vol.45, pp.99-100, 2019. ,
Cost of depression in Europe, J. Ment. Health Policy Econ, vol.9, pp.87-98, 2006. ,
The economic burden of adults with major depressive disorder in the United States, J. Clin. Psychiatry, vol.76, pp.155-162, 2005. ,
Updating of the French recommendations for the first-line treatment of major depression, L'Encephale, vol.45, pp.457-458, 2019. ,
DALYs and HALE Collaborators Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: A systematic analysis for the global burden of disease study 2016, Lancet Lond. Engl, vol.390, pp.1260-1344, 2016. ,
Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort, Schizophr. Res, vol.185, pp.173-181, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01792072
Remission of depression in patients with schizophrenia and comorbid major depressive disorder: Results from the FACE-SZ cohort, Br. J. Psychiatry, vol.213, pp.464-470, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01814845
A structural equation modelling approach to explore the determinants of quality of life in schizophrenia, Schizophr. Res, vol.171, pp.27-34, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01482502
Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohort, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.94, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02473659
The common pathophysiology underlying the metabolic syndrome, schizophrenia and depression. A review, Biomed. Pap. Med. Fac. Univ. Palacký Olomouc Czechoslov, vol.159, pp.208-214, 2015. ,
Treatment of depression in schizophrenia: Systematic review and meta-analysis, Br. J. Psychiatry J. Ment. Sci, vol.211, pp.198-204, 2017. ,
Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort, J. Psychiatr. Res, vol.94, pp.62-69, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01696840
Self-reported pain in patients with schizophrenia. Results from the national first-step FACE-SZ cohort, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.85, pp.62-68, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01814764
Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: Analysis of the CATIE phase 2E data, Schizophr. Res, vol.161, pp.429-433, 2015. ,
Mental health research priorities for Europe, Lancet Psychiatry, vol.2, pp.1036-1042, 2015. ,
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: A systematic review and network meta-analysis, Lancet Lond. Engl, vol.391, pp.1357-1366, 2018. ,
Microbiota-gut-brain axis and the central nervous system, Oncotarget, vol.8, pp.53829-53838, 2017. ,
The potential role of microbiota in major psychiatric disorders: Mechanisms, preclinical data, gastro-intestinal comorbidities and therapeutic options, Presse Med. Paris Fr, vol.45, pp.7-19, 1983. ,
Absence of gut microbiota influences lipopolysaccharide-induced behavioral changes in mice, Behav. Brain Res, vol.312, pp.186-194, 2016. ,
Gastroenterology issues in schizophrenia: Why the gut matters, Curr. Psychiatry Rep, vol.17, 2015. ,
Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia, Schizophr. Res, vol.148, pp.130-137, 2013. ,
C-reactive protein as a peripheral biomarker in schizophrenia. An updated systematic review, Front. Psychiatry, vol.9, p.392, 2018. ,
Antigliadin antibodies (AGA IgG) are related to neurochemistry in schizophrenia, vol.8, 2017. ,
immunoregulatory old friends and psychiatric disorders, Adv. Exp. Med. Biol, vol.817, pp.319-356, 2014. ,
The role of the gut microbiota in schizophrenia: Current and future perspectives, World J. Biol. Psychiatry Off. J. World Fed. Soc. Biol. Psychiatry, vol.19, pp.571-585, 2018. ,
Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response, Schizophr. Res, vol.192, pp.398-403, 2018. ,
Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study, Schizophr. Res, vol.197, pp.470-477, 2018. ,
Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort, Schizophr. Res, vol.168, pp.388-394, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01755227
Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort, Eur. Arch. Psychiatry Clin. Neurosci, vol.269, pp.985-992, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02473643
Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: Results from the national FACE-SZ cohort, Eur. Arch. Psychiatry Clin. Neurosci, vol.268, pp.541-553, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01696697
Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: Results from the national multicentric FACE-SZ cohort, Eur. Arch. Psychiatry Clin. Neurosci, vol.267, pp.465-472, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01779626
Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set, J. Affect. Disord, vol.191, pp.209-215, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01482510
High C-reactive protein levels are associated with depressive symptoms in schizophrenia, J. Affect. Disord, vol.225, pp.671-675, 2018. ,
PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement, Br. Med. J, vol.339, 2009. ,
Anxiety and depression comorbidities in irritable bowel syndrome (IBS): A systematic review and meta-analysis, Eur. Arch. Psychiatry Clin. Neurosci, vol.264, pp.651-660, 2014. ,
A Microbial signature of psychological distress in irritable bowel syndrome, Psychosom. Med, vol.80, pp.698-709, 2018. ,
Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat, J. Psychiatr. Res, vol.82, pp.109-118, 2016. ,
Correlation between the human fecal microbiota and depression, Neurogastroenterol. Motil. Off. J. Eur. Gastrointest. Motil. Soc, vol.26, pp.1155-1162, 2014. ,
The intestinal microbiota in acute anorexia nervosa and during renourishment: Relationship to depression, anxiety, and eating disorder psychopathology, Psychosom. Med, vol.77, pp.969-981, 2015. ,
Similar fecal microbiota signatures in patients with diarrhea-predominant irritable bowel syndrome and patients with depression, Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc, vol.14, pp.1602-1611, 2016. ,
Altered fecal microbiota composition in patients with major depressive disorder, Brain. Behav. Immun, vol.48, pp.186-194, 2015. ,
Sex differences in gut microbiota in patients with major depressive disorder, Neuropsychiatr. Dis. Treat, vol.14, pp.647-655, 2018. ,
Comparative metaproteomics analysis shows altered fecal microbiota signatures in patients with major depressive disorder, Neuroreport, vol.29, pp.417-425, 2018. ,
Reduced anti-inflammatory gut microbiota are associated with depression and anhedonia, J. Affect. Disord, vol.266, pp.394-401, 2020. ,
The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness, J. Affect. Disord, vol.2020, pp.98-106 ,
Prevotella and Klebsiella proportions in fecal microbial communities are potential characteristic parameters for patients with major depressive disorder, J. Affect. Disord, vol.207, pp.300-304, 2017. ,
A systematic review of the effect of probiotic supplementation on schizophrenia symptoms, Neuropsychobiology, vol.78, pp.1-6, 2019. ,
Marital distress, depression, and a leaky gut: Translocation of bacterial endotoxin as a pathway to inflammation, Psychoneuroendocrinology, vol.98, pp.52-60, 2018. ,
Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials, Neurosci. Biobehav. Rev, vol.102, pp.13-23, 2019. ,
Fecal microbiota transplantation: Indications and perspectives, vol.32, pp.991-997, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01453285
Bouillabaisse or fish soup: The Limitations of meta-analysis confronted to the inconsistency of fecal microbiota transplantation studies, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02507368
Faecal microbiota transplantation-the Austrian approach, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.20, pp.1106-1111, 2014. ,
Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: Safety, feasibility, and efficacy trial results, J. Gastroenterol. Hepatol, vol.30, pp.51-58, 2015. ,
Early fecal microbiota transplantation improves survival in severe clostridium difficile infections, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am, vol.66, pp.645-650, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01780637
Duodenal infusion of donor feces for recurrent Clostridium difficile, N. Engl. J. Med, vol.368, pp.407-415, 2013. ,
Fecal microbiota transplantation in the treatment of Clostridium difficile infections, Am. J. Med, vol.127, pp.479-483, 2014. ,
Randomised clinical trial: Faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection, Aliment. Pharmacol. Ther, vol.41, pp.835-843, 2015. ,
Systematic review with meta-analysis: Long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection, Aliment. Pharmacol. Ther, vol.43, pp.445-457, 2016. ,
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: A randomised placebo-controlled trial, Lancet, vol.389, pp.1218-1228, 2017. ,
Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: A randomized clinical trial, JAMA, vol.321, pp.156-164, 2019. ,
Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: A double-blind, randomised, placebo-controlled, parallel-group, single-centre trial, Lancet Gastroenterol. Hepatol, vol.3, pp.17-24, 2018. ,
Systematic review: Adverse events of fecal microbiota transplantation, PLoS ONE, vol.11, 2016. ,
Obesity and the gut microbiota, J. Clin. Gastroenterol, vol.45, pp.128-132, 2011. ,
Capsules for fecal microbiota transplantation in recurrent clostridium difficile Infection: The new way forward or a tough pill to swallow?, JAMA, vol.318, 1979. ,
Effect of oral capsule-vs colonoscopy-delivered fecal microbiota transplantation on recurrent clostridium difficile infection: A randomized clinical trial, JAMA, vol.318, 1985. ,
Successful resolution of recurrent clostridium difficile infection using freeze-dried, encapsulated fecal microbiota; pragmatic cohort study, Am. J. Gastroenterol, vol.112, pp.940-947, 2017. ,
, This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, © 2020 by the authors. Licensee MDPI